liver tissues; sera
-
not specified
RT-qPCR; Clinical Sample Validation; ROC Analysis; Cohort Study
serum hsa-cVIM differentiates CHB patients with liver fibrosis from healthy controls (AUC 0.895) and increases with fibrosis stage
In human CHB/CHC-related liver fibrosis, hsa_circ_0017884 (hsa-cVIM) is upregulated in liver tissue and serum. Serum hsa-cVIM shows diagnostic utility for liver fibrosis and correlates positively with fibrosis stage.
0.4758
Circular RNA cVIM promotes hepatic stellate cell activation in liver fibrosis via miR-122-5p/miR-9-5p-mediated TGF-beta signaling cascade.
clinical study